The classical drug discovery paradigm begins with a known molecular target: a protein whose modulation is expected to reverse ...

Researchers created Compound 10 to block GRK2 enzyme aggregation and protect mitochondria in Alzheimer's disease.

Predictive Oncology Inc. announced the successful development of predictive models for 21 unique compounds sourced from the University of Michigan's Natural Products Discovery Core, marking a ...

Researchers studied GRK2 in human tissue and mouse models. They found inactive GRK2 aggregates drive damage and amyloid build ...

Scientists at Washington University School of Medicine in St. Louis have developed a chemical compound that interferes with a key feature of many viruses that allows the viruses to invade human cells.

A new generation of compounds is being studied for its potential to support brain plasticity and adaptive change, potentially reshaping how mental health conditions are treated.